A federal judge on Monday threw out a $96 million jury verdict against genetic testing company CareDX that rival Natera had ...

Genetic testing company Natera (NASDAQ:NTRA). will be announcing earnings results tomorrow after market close. Here’s what to ...

Medical diagnostics company Guardant Health has sued rival Natera in California federal court for allegedly stealing trade ...

Natera Inc (NASDAQ:NTRA) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 2024 revenue ...

Natera (NTRA) announced that its Signatera test has met coverage requirements from the Centers for Medicare & Medicaid Services’ Molecular ...

Natera (NASDAQ:NTRA – Get Free Report) is anticipated to issue its quarterly earnings data after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of ...

Learn more about whether Alnylam Pharmaceuticals, Inc. or Natera, Inc. is a better investment based on AAII's A+ Investor ...

Learn more about whether Insmed Incorporated or Natera, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high- ...

In its fourth quarter 2024 investor letter, Baron Health Care Fund emphasized stocks such as Natera, Inc. (NASDAQ:NTRA). Natera, Inc. (NASDAQ:NTRA) is a diagnostics company that develops and ...